Freya Biosciences ApS
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle (NCT07453069) | Freya Biosciences ApS | 2026-04-15 |
| Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial (NCT07481955) | Freya Biosciences ApS | 2026-03-23 |
| FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3) (NCT05850078) | Freya Biosciences ApS | 2023-05-18 |
| Vaginal Microbiome and IVF Pregnancy Outcome (NCT05150639) | Freya Biosciences ApS | 2022-03-18 |
| FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (NCT05114031) | Freya Biosciences ApS | 2021-10-20 |
Track Freya Biosciences ApS automatically
Every clearance here is in the API, with alerts when new ones post.